Authors

Elisabeth Ng

MBBS (Hons), Endocrinology Registrar, Department of Endocrinology, Monash Health, Clayton, Vic


Glucagon-like peptide-1 receptor agonist (GLP1-RA) therapy in type 2 diabetes

Numerous glucose-lowering medications have been developed in recent years with growing evidence relating to their efficacy and safety.